Debate over Electronic Cigarette Marketing to Minors

Apr.04.2023
Debate over Electronic Cigarette Marketing to Minors
UK Advertising Standards Agency denies claims that e-cigarette companies target minors in documentary investigation.

On April 3rd, according to the Daily Mail, British investigators examined packaging and flavors of electronic cigarettes in a documentary that exposed the prevalence of e-cigarettes in the UK. Underage individuals who have become addicted to e-cigarettes claim that manufacturers are using marketing tactics aimed at them, which supports the opinions of experts.


However, in a statement given to Sky, the Advertising Standards Authority (ASA) in the UK stated that there is no evidence to suggest that e-cigarette companies are targeting underage individuals and that advertisements should not be held responsible for encouraging addictive habits in children.


The ASA stated in a complete statement to the Daily Mail that although they are aware of the reasonable concern surrounding the use of e-cigarettes by minors, the current evidence they are reviewing does not indicate that marketing is the driving factor behind minors using e-cigarettes.


Although electronic cigarette products with bright colors and strong flavors may have potential appeal, there is no evidence yet that companies are targeting minors through advertisements.


Reference:


Vaping products are not intentionally marketed or targeted towards children.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

PMI’s Japan unit to raise IQOS ILUMA stick prices; TEREA and SENTIA to increase from April
PMI’s Japan unit to raise IQOS ILUMA stick prices; TEREA and SENTIA to increase from April
Japan will adjust tobacco taxes from April 1, 2026, prompting Philip Morris International (PMI) to lift prices for its IQOS ILUMA tobacco sticks TEREA and SENTIA. Both products are set to rise by 40 yen per pack (about $0.3).
Jan.21 by 2FIRSTS.ai
Federal Register notice: FDA seeks comments on “Warning Plans for Certain Tobacco Products”
Federal Register notice: FDA seeks comments on “Warning Plans for Certain Tobacco Products”
The U.S. Food and Drug Administration (FDA) issued a notice stating it has submitted a proposed information collection to the Office of Management and Budget (OMB) for review under the Paperwork Reduction Act.
Jan.16 by 2FIRSTS.ai
British American Tobacco to close South Africa cigarette plant by end-2026, citing illicit trade squeezing legal market
British American Tobacco to close South Africa cigarette plant by end-2026, citing illicit trade squeezing legal market
British American Tobacco South Africa (BATSA) said it will halt local production of factory-made cigarettes and close its manufacturing plant in Heidelberg, Gauteng by the end of 2026, shifting to an import-led supply model. The company said illicit cigarettes now account for about 75% of South Africa’s market, making local manufacturing “unsustainable” and putting around 230 jobs at risk.
Jan.16
Imperial Brands Forms Global AI Partnership with Capgemini, Reinforcing Artificial Intelligence as Core Infrastructure in the Nicotine Industry
Imperial Brands Forms Global AI Partnership with Capgemini, Reinforcing Artificial Intelligence as Core Infrastructure in the Nicotine Industry
Industry Insight
Feb.19
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
U.S.-based medical startup Qnovia Inc. reported positive results from its first-in-human clinical trial of RespiRx, an inhalable nicotine replacement therapy (NRT) device designed to support smoking cessation.
Innovation
Feb.24
Japan Tobacco Launches Limited-Edition “Purple Dusk” Colorway for Ploom AURA, Priced at JPY 2,980
Japan Tobacco Launches Limited-Edition “Purple Dusk” Colorway for Ploom AURA, Priced at JPY 2,980
Japan Tobacco has launched the fourth installment of its limited-color series for the Ploom AURA heated-tobacco device, unveiling “Purple Dusk” . Priced at JPY 2,980 (about USD 18.7, tax included), it goes on limited early sale via official channels from Jan 13, before rolling out to convenience stores and other retail outlets across Japan from Jan 20.
Jan.13 by 2FIRSTS.ai